Pure Global

Synthetic Bone substitute - India CDSCO Medical Device Registration

Synthetic Bone substitute is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000309_b95ba117fff72df48cd20f0715d5431a_e337ebcd9d6faa905636084b5834f14c. This device is marketed under the brand name MBCP, B-Wedge. The license holder is Chetan Meditech Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Synthetic Bone substitute
UID: IMP/MD/2020/000309_b95ba117fff72df48cd20f0715d5431a_e337ebcd9d6faa905636084b5834f14c

Brand Name

MBCP, B-Wedge

Device Class

Class D

Approving Authority

CDSCO

Product Information

The Synthetic Bone Substitute is intended for use as a bone void filler for bony voids or gaps of the skeletal system (MBCP, B-Wedge) that are not intrinsic to the stability of the bony structure. The Synthetic Bone Substitute can be used with autograft as a bone graft extender. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The Synthetic Bone Substitute is a bone filler without initial mechanical properties. Therefore rigid fixation techniques may often be recommended. When packed into a bony site, The Synthetic Bone Substitute gradually resorbs and is replaced with bone during the healing process. In addition, when used with appropriate opening osteotomy system devices, plates and screws. The Synthetic Bone substitute is intended to be used as a bone void filler in femoral or tibial osteotomies. The Synthetic Bone Substitute is to be used in association with adequate post-operative immobilization

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing